Bicara Therapeutics President and COO Ryan Cohlhepp reports disposal of USD 817,447.74 common shares - BCAX News | RalliesBicara Therapeutics President and COO Ryan Cohlhepp reports disposal of USD 817,447.74 common shares
B
BCAX• Cohlhepp cuts direct common-stock stake
- Bicara Therapeutics President, COO, director Ryan Cohlhepp cut his direct common-stock stake to 181,641 shares.
- Sold 28,750 shares on July 8-9 at prices around USD 28.76 to USD 30.35.
- Exercised options for 18,750 shares at USD 3.79 on July 8.
•
